Article in Journal of the American Society of Nephrology : JASN, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors.
Pascale KhairallahDivision of Nephrology, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
Satoru KudoseDepartment of Pathology and Cell Biology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York.ORCID 0000-0001-8396-9877
Heather K MorrisDivision of Nephrology, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
Lloyd E RatnerDepartment of Surgery, Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
Sumit MohanDivision of Nephrology, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
Jai RadhakrishnanDivision of Nephrology, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
Jae-Hyung ChangDivision of Nephrology, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, New York jhc2170@cumc.columbia.edu.
Funding
5/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical CenterU01DK116066 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Sumit Mohan, Deirdre Sawinski · 2017 to 2026
$2.5M
Identifying and exploring solutions to the ethical challenges of ApoL1 testing of donors with recent African ancestry through mixed methods research with stakeholdersR01MD014161 · NIMHD · WASHINGTON UNIVERSITY · PI DUBOIS, JAMES M, MOHAN, SUMIT · 2019 to 2021
$1.2M
Increasing Minority Population Awareness through Community Teaching for Improved Organ Donation (IMPACT for Improved Organ Donation)R01DK114893 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MOHAN, SUMIT · 2017 to 2021
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Reversal of Donor Hepatitis C Virus-Related Mesangial Proliferative GN in a Kidney Transplant Recipient. · full record | OpenQuestion